Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double‐blind, placebo‐controlled clinical trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double‐blind, placebo‐controlled clinical trial
Authors
Keywords
-
Journal
PSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-29
DOI
10.1111/pcn.13016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice
- (2019) Ahmed Nadeem et al. BEHAVIOURAL BRAIN RESEARCH
- New highlights on the health-improving effects of sulforaphane
- (2018) Alfredo Briones-Herrera et al. Food & Function
- Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
- (2018) Stephen Bent et al. Molecular Autism
- Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
- (2018) Jung Won Kim et al. Clinical Psychopharmacology and Neuroscience
- Isothiocyanate from Broccoli, Sulforaphane, and Its Properties
- (2018) Alena Vanduchova et al. JOURNAL OF MEDICINAL FOOD
- Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice
- (2018) Pablo Ferreira-Chamorro et al. Frontiers in Pharmacology
- Autism Spectrum Disorders — Diagnosis and Management
- (2017) Sharmila Banerjee Mukherjee INDIAN JOURNAL OF PEDIATRICS
- The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism
- (2017) William Parker et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation
- (2017) Ji-chun Zhang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder
- (2017) Anne Masi et al. Neuroscience Bulletin
- Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders
- (2016) Kunio Yui et al. CNS & Neurological Disorders-Drug Targets
- Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia
- (2016) Vicente Hernandez-Rabaza et al. Journal of Neuroinflammation
- Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism
- (2016) Sheikh Fayaz Ahmad et al. MOLECULAR NEUROBIOLOGY
- Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care
- (2016) K. McGuire et al. PEDIATRICS
- Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders
- (2015) Ningan Xu et al. MEDIATORS OF INFLAMMATION
- Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
- (2015) Irena Smaga et al. Pharmacological Reports
- A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
- (2015) Ali Ghaleiha et al. PSYCHIATRY RESEARCH
- Drug therapy in autism: a present and future perspective
- (2014) Baldeep Kumar et al. Pharmacological Reports
- Sulforaphane treatment of autism spectrum disorder (ASD)
- (2014) K. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The epidemiology and global burden of autism spectrum disorders
- (2014) A. J. Baxter et al. PSYCHOLOGICAL MEDICINE
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
- (2013) Nazila Shahmansouri et al. JOURNAL OF AFFECTIVE DISORDERS
- Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
- (2013) Ali Ghaleiha et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
- (2013) Ali Ghaleiha et al. PEDIATRIC DRUGS
- Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells
- (2013) Megan L. Steele et al. Redox Biology
- Autism spectrum disorders
- (2012) Alexis Tchaconas et al. CURRENT OPINION IN PEDIATRICS
- Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder
- (2012) Danial Khajavi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
- (2012) Mahtab Asadabadi et al. PSYCHOPHARMACOLOGY
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
- (2011) Ebrahim Haroon et al. NEUROPSYCHOPHARMACOLOGY
- Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
- (2011) James B Adams et al. Nutrition & Metabolism
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
- (2010) Paul Ashwood et al. BRAIN BEHAVIOR AND IMMUNITY
- Defining the cognitive phenotype of autism
- (2010) T. Charman et al. BRAIN RESEARCH
- Elevated immune response in the brain of autistic patients
- (2009) Xiaohong Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
- (2009) Shahin Akhondzadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
- (2007) Shahrokh Amiri et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now